Endocrine therapy is generally recommended for patients with HR+/HER2-metastatic breast cancer, with the exception of those ...

Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new ...

A new study suggests that many women with early-stage breast cancer may not need radiation after a mastectomy, thanks to ...

Exercise can help women with advanced breast cancer better withstand both cancer treatments and the ravages of the disease, a ...

Use of proton pump inhibitors (PPIs) alongside anti-cancer agents was associated with worse survival outcomes in patients ...

Researchers from The University of Texas Medical Branch in Galveston, Texas, along with collaborators in Houston, reported ...

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the ...

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

People with HER2+/HR+ advanced breast cancer had the longest survival times — 42 months on average at the start and 53 months ...

Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer ...

AlohaCare members, including those enrolled in Medicaid and Medicare, will have more access to medical equipment like breast ...